These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 9872516

  • 1. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M, Figura N.
    J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [Abstract] [Full Text] [Related]

  • 2. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
    Marusic M, Babic Z, Nesanovic M, Lucijanic-Mlinac M, Stajcar V.
    World J Gastroenterol; 2005 Apr 21; 11(15):2334-6. PubMed ID: 15818748
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS, Berardi RR.
    J Am Pharm Assoc (Wash); 2000 Apr 21; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [Abstract] [Full Text] [Related]

  • 4. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M, Malfertheiner P.
    Helicobacter; 1998 Mar 21; 3(1):21-7. PubMed ID: 9546114
    [Abstract] [Full Text] [Related]

  • 5. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E, Romagnoli P, Fasoli A, Chiarbonello B, Malfatti F, Botta F, Risso D, Lantieri PB, Savarino V, Testa R.
    Am J Gastroenterol; 2000 Oct 21; 95(10):2762-7. PubMed ID: 11051345
    [Abstract] [Full Text] [Related]

  • 6. Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review.
    Ulmer HJ, Beckerling A, Gatz G.
    Helicobacter; 2003 Apr 21; 8(2):95-104. PubMed ID: 12662376
    [Abstract] [Full Text] [Related]

  • 7. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A, Perri F, Leandro G, Franceschi M, Aging and Acid-Related Disease Study Group.
    Gerontology; 2006 Apr 21; 52(2):99-106. PubMed ID: 16508317
    [Abstract] [Full Text] [Related]

  • 8. Review article: rabeprazole-based therapy in Helicobacter pylori eradication.
    Barth J, Hahne W.
    Aliment Pharmacol Ther; 2002 Mar 21; 16 Suppl 1():31-3. PubMed ID: 11849125
    [Abstract] [Full Text] [Related]

  • 9. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis.
    Gisbert JP, Khorrami S, Calvet X, Pajares JM.
    Eur J Gastroenterol Hepatol; 2004 Jan 21; 16(1):89-99. PubMed ID: 15095858
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
    Cui M, Hu F, Jiang H, Zheng X.
    Zhonghua Yi Xue Za Zhi; 2002 Sep 25; 82(18):1245-8. PubMed ID: 12425803
    [Abstract] [Full Text] [Related]

  • 11. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Sep 25; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 12. Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.
    Thomson AB.
    Curr Gastroenterol Rep; 2000 Dec 25; 2(6):482-93. PubMed ID: 11079051
    [Abstract] [Full Text] [Related]

  • 13. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
    Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M, Moss SF, Niv Y, Avni Y, Shirin H.
    Aliment Pharmacol Ther; 2004 Jul 01; 20(1):117-22. PubMed ID: 15225178
    [Abstract] [Full Text] [Related]

  • 14. Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective.
    Furuta T, Shirai N, Sugimoto M, Ohashi K, Ishizaki T.
    Aliment Pharmacol Ther; 2003 Dec 01; 18(11-12):1175-6. PubMed ID: 14653841
    [No Abstract] [Full Text] [Related]

  • 15. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
    Gawrońska-Szklarz B, Wrześniewska J, Starzyńska T, Pawlik A, Safranow K, Ferenc K, Droździk M.
    Eur J Clin Pharmacol; 2005 Jul 01; 61(5-6):375-9. PubMed ID: 15976989
    [Abstract] [Full Text] [Related]

  • 16. Which proton pump inhibitor should we use?
    Williams CN.
    Can J Gastroenterol; 1997 Jul 01; 11(1):29. PubMed ID: 9113794
    [No Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
    Pilotto A, Franceschi M, Longoa MG, Scarcelli C, Orsitto G, Perri FC, D'Ambrosio LP, Leandro G.
    Dig Liver Dis; 2004 Oct 01; 36(10):666-70. PubMed ID: 15506665
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole and Helicobacter pylori infection.
    Pallone F, Luzza F, Delle Fave G, Annibale B, Marcheggiano A, Biancone L, Torsoli A, Capurso L.
    Clin Ther; 1993 Oct 01; 15 Suppl B():49-57. PubMed ID: 8205595
    [Abstract] [Full Text] [Related]

  • 19. In treatment of active duodenal ulcer and Helicobacter pylori eradication.
    Yukselen V, Yasa MH, Karaoglu AO.
    Hepatogastroenterology; 2003 Dec 01; 50 Suppl 2():cccvi-cccviii. PubMed ID: 15244210
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of lansoprazole in eradication of Helicobacter pylori.
    Takimoto T, Ido K, Taniguchi Y, Satoh K, Saifuku K, Kihira K, Yoshida Y, Kimura K.
    J Clin Gastroenterol; 1995 Dec 01; 20 Suppl 2():S121-4. PubMed ID: 7594327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.